The complete blood count device market comprises of hematology analyzers and reagents designed for counting and differentiating blood cells, especially red blood cells and white blood cells. Complete blood count tests help diagnose diseases related to blood by providing important information such as an individual's red blood cell count, white blood cell count, hemoglobin level, hematocrit level, platelet count and other cell counts. The rising prevalence of lifestyle-related chronic diseases such as diabetes, cardiovascular diseases, and cancers globally is fueling the demand for CBC tests to evaluate various health risk factors. Conventional CBC tests are transitioning towards automated analyzers providing faster, safer and more reliable test results.

The global complete blood count device market is estimated to be valued at US$ $4,627.35 million in 2021, and is expected to exhibit a CAGR of 8.3% over the forecast period (2021-2028).



Key Takeaways

Key players operating in the complete blood count device market are Sonoco Products Company, Amcor Plc, International Paper Company, Sealed Air Corp., Huhtamaki Oyj, Amcor Plc , Linpac Group Ltd., Ampac Holdings LLC, INDEVCO Group, Tetra Laval, Berry Global, Stora Enso, and SIG. Sonoco Products Company and Amcor Plc hold the major market share in the CBC device packaging market globally.



The rising global disease burden has increased the demand for diagnostics testing, presenting tremendous opportunities for CBC device manufacturers to expand their product offerings and geographic footprint Complete Blood Count Device Market Growth. Portable and home use devices with advanced features are expected witness high growth in the coming years.



Key players are actively pursuing opportunities in emerging markets through partnerships and acquisitions. For instance, In 2021, Beckman Coulter Diagnostics completed the acquisition of the clinical diagnostics business of Ortho Clinical Diagnostics to expand network in Latin America and Asia Pacific regions. Rising healthcare infrastructure investment programs in developing nations will encourage global expansion of complete blood count device companies.



Market Drivers

Growth in geriatric population worldwide accompanied by increasing risk of age-related diseases is a major factor driving the Complete Blood Count Device Market Size and Trends. According to United Nations estimates, the geriatric population is expected to reach over 2 billion by 2050 from 900 million in 2015. Older adults are more prone to chronic illnesses requiring ongoing monitoring through CBC testing.



Market Restraints

High capital investment and maintenance costs associated with automated hematology analyzers limit their adoption, especially in resource-poor regions. Product recalls owing to quality issues also negatively impact market revenues. For instance, in 2019, Ortho Clinical Diagnostics issued a voluntary recall of some insulin syringes owing to inaccurate dosing caused by manufacturing defects. Stringent regulatory processes also restraint market growth to some extent.

Segment Analysis

The complete blood count device market is segmented based on product type, end user and region. Within product type, hematology analyzers dominate the market. Hematology analyzers provide an automated and accurate way to count and classify blood cells and platelets in whole blood. They offer volume, number, and morphological data on red blood cells, white blood cells, and platelets for the diagnosis and monitoring of various diseases. The growing demand for precise and efficient blood analysis is driving the hematology analyzers segment. By end user, hospitals account for the largest share in the complete blood count device market. Hospitals perform a large number of blood tests on a daily basis for diagnosis and monitoring various diseases. They also require automated and advanced hematology equipment that can handle high testing volumes efficiently. This makes hospitals the major end users of complete blood count devices.



Global Analysis



The North America region holds the largest share in the complete blood count device market, primarily due to presence of major players, developed healthcare infrastructure, and growing incidence of target diseases. Rising healthcare expenditure in countries like United States and Canada also contributes to the leading position of North America. The significant scope for upgradation of existing testing technologies also supports market growth in this region.

However, Asia Pacific region is expected to exhibit the highest growth during the forecast period. Developing healthcare infrastructure, increasing healthcare spending, rising awareness regarding blood disorder treatment and rapid economic growth are driving the demand for complete blood count devices in Asia Pacific region. Especially, China and India are expected to offer lucrative opportunities due to large patient population, increasing medical tourism and government initiatives to modernize healthcare facilities.

Discover the Report for More Insights, Tailored to Your Language:

About Author:

Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.

(LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91)